The largest database of trusted experimental protocols

2 protocols using anti nkp30 pe

1

Characterization of Isolated NK Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The purity of isolated NK cells (>95%) and expression of surface receptors were determined by flow cytometry using a FACSCalibur (BD-Biosciences). NK cell population was defined as NKp46+CD3 cells.
Changes in the expression of NK cell receptors were examined using the following antibodies: anti-NKp30 PE (Biolegend), anti-NKp44 PE (Biolegend), anti-NKG2D PE (BD-Biosciences), anti-CD16 FITC (Miltenyi Biotec), anti-CD56 FITC and APC (BD-Biosciences), anti-2B4 FITC (Biolegend), anti-NTB-A PE (Biolegend), anti-Dectin-1 PE, anti-TLR-2 PE and anti-TLR-4 PE (BD-Biosciences). Apoptotic NK cells were assessed after an incubation time of 9 h using Annexin V FITC (BD-Biosciences) after staining cells with the surface marker antibodies anti-NKp46 PE, anti-CD3 PerCP and anti-CD56 APC. Intracellular expression of CD56 after incubation with germ tubes for 6 h was investigated by firstly staining CD56 on the cell surface with anti-CD56 FITC (BD-Biosciences). Then, cells were fixed (4% formaldehyde), permeabilized (Wash Perm, BD-Biosciences) and intracellular CD56 was stained using anti-CD56 APC (BD-Biosciences). To remove surface markers, NK cells were incubated in 0.5% trypsin-EDTA (Sigma) for 30 min at 37 °C before samples were stained. All data were analyzed with FlowJo software (Tree Star Inc.).
+ Open protocol
+ Expand
2

NKTR-255 Modulation of NK Cell Phenotype

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total PBMCs were collected and cultured at 0.5 to 1 × 106 cells/mL with NKTR-255 at a concentration of 1000 ng/mL. NK cells were recognized and gated as CD3-CD56+ and expression of the different markers was assessed at baseline and after treatment, taking the median fluorescence intensity as reference. For this assay the following combination of fluorochrome conjugated anti-human monoclonal antibodies was employed: anti-CD3-PE/Cy7 (Biolegend, Cat.#300420), anti-CD56-BV786 (BD Biosciences, Cat.#564058), anti-NKG2A-APC (R&D Systems [Minneapolis, MN] Cat.#FAB1059A-100), anti-NKG2C-AlexaFluor488 (R&D Systems, Cat.#FAB138G-025), anti-NKG2D-BV421 (Biolegend, Cat.#320821), anti-NKp30-PE (Biolegend, Cat.#325207), anti-NKp46-BV421 (Biolegend, Cat.#331914), anti-DNAM1-APC (Biolegend, Cat.#338311), anti-LAG3-FITC (Invitrogen [Waltham, MA], Cat.#11-2239-42), anti-TRAIL-PE (Biolegend, Cat.#308206), anti-TIGIT-FITC (Invitrogen, Cat.#11-9500-42) and anti-KIR2D-PE (Biolegend, Cat.#312606). LIVE/DEAD fixable dead cell stain (ThermoFisher Scientific [Waltham, MA], Cat.#L34966) was included to label and discard dead cells. Analysis was performed using a BD LSRFortessa X-20 (BD Biosciences) cytometer and FlowJo v9 (FlowJo LLC, Ashland, OR) software.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!